Highlight Sneak Peek : What's Happening at Longevity Day 🧬

Key Takeaways

• Breath Lab offers live EEG visualization of breath‑induced brainwave shifts
• Dr. Sabine Krofczik‑Wilhelm leads hands‑on longevity protocol workshop
• 26 experts discuss biomarkers, stem cells, DeSci, AI health tools
• Investment panel features Marvin Amberg, Sebastian Brunemeier, Yang Chen

Pulse Analysis

Longevity Day at NFC Summit reflects a broader shift as the global longevity market, projected to exceed $30 billion by 2030, moves from niche labs into public forums. By assembling scientists, venture capitalists and Web3 creators under one roof, the event underscores how interdisciplinary collaboration is becoming a prerequisite for breakthroughs in age‑related therapies. Attendees can expect to hear the latest on biomarkers, stem‑cell interventions, and decentralized science platforms that aim to democratize research funding, all of which are reshaping the investment landscape for healthspan technologies.

A standout feature, the Breath Lab, merges experiential neuroscience with real‑time data streaming. Participants engage in CO₂‑intermittent breath holds while an EEG captures shifts in brainwave activity, projecting the results onto a shared screen. This immersive format not only demystifies complex neurophysiology but also illustrates a growing trend: using biofeedback experiences to educate and attract both consumers and potential backers. Such live demonstrations help bridge the gap between abstract research and tangible user outcomes, a critical factor for commercializing neuro‑enhancement tools.

Beyond the scientific showcase, Longevity Day’s investment panel—featuring Marvin Amberg, Sebastian Brunemeier and Yang Chen—highlights the influx of capital seeking to back AI‑driven health platforms and radical longevity ventures. Coupled with NFC Summit’s identity as the world’s first Web3 pop‑culture festival, the event creates a unique ecosystem where tokenized funding models, NFT‑based community building, and traditional venture financing intersect. This hybrid approach is likely to accelerate the scaling of longevity startups, positioning Lisbon as a new epicenter for health‑tech innovation.